Session Information
Session Title: Innate Immunity and Rheumatic Disease
Session Type: Abstract Submissions (ACR)
Background/Purpose: The receptor for advanced glycation end products (RAGE) is a multi-ligand receptor expressed on various cells which interacts with a diverse class of ligands, e.g. ‘danger signals’ such as neutrophil-derived S100A12. RAGE has been implicated in the pathogenicity of various inflammatory diseases including inflammatory arthritis. However, the exact role of RAGE has not been sufficiently defined. Our recent data on S100A12-induced activation of monocytes points to a modulatory rather than pro-inflammatory function of human RAGE. To assess the role of RAGE in a more systematic way, we generated RAGE-/- mice and analyzed immune cell functions in vitro, followed by murine models of staphylococcus aureus infection (host defense), chemically induced colitis (mucosal immunity), lethal inflammatory liver injury (septic shock) and collagen induced arthritis (autoimmunity) comparing RAGE-/- and C57BL/6 wildtype (wt) mice.
Methods: Reactive oxygen species (ROS) production, phagocytosis and cytokine production of bone marrow derived monocytes were measured using flow cytometry. Staphylococcus aureus (S. aureus)infection was induced by footpad injection. Acute and chronic colitis were induced chemically by dextran sodium sulfate (DSS) solution. For the inflammatory liver injury model, mice were challenged with D-galactosamine (D-Gal) along with lipopolysaccharide (LPS). Arthritis was induced by injection of heterologous type II collagen (CII).
Results: We observed no differences of cellular immune function (ROS and cytokine production, phagocytosis) in RAGE-/- compared to wt monocytes. Male, but not female RAGE-/- mice showed more footpad swelling and bacterial dissemination in the S. aureus infection model. In the DSS colitis model we observed no significant differences between the two strains, whereas RAGE-/- mice were significantly protected from lethal D‑Gal/LPS induced liver injury. RAGE-/- and wt mice develop arthritis at similar clinical scores and incidence with no significant differences in type II collagen autoantibody levels. However, in female animals there is a strong tendency towards aggravated disease, less remission and higher disease penetrance.
Conclusion: Overall, the contribution of RAGE seems to largely depend on the disease model and cell type studied. While no overall differences with respect to immune cell activities were observed, a striking gender-specific effect of RAGE seems to be involved in some conditions, especially in arthritis. The exact role of RAGE and its soluble form (sRAGE) during the development of arthritis and the influence of gender-specific factors is under further investigation.
Disclosure:
T. Wirth,
None;
C. Kessel,
None;
P. Becker,
None;
T. Weinhage,
None;
N. Nippe,
None;
D. Foell,
None.
« Back to 2013 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-receptor-for-advanced-glycation-end-products-rage-as-a-modulator-of-inflammatory-responses-and-its-contribution-to-gender-specific-effects-during-arthritis/